Emerging evidence indicates that ADSC-derived exosomes (ADSCs-Exos) from diabetic patients may remodel the tumor microenvironment, potentially promoting the growth of estrogen receptor (ER)-positive breast cancer (Jafari et al., 2021). This evidence concerns the gene ESR1 and neoplasm.